“Rivaroxaban versus Warfarin for Prevention of Thromboembolism in Bangladeshi Patients with Non-Valvular Atrial Fibrillation” (2020) University Heart Journal, 16(2), pp. 99–105. doi:10.3329/uhj.v16i2.49666.